- Home
- VIR vs ACIC Comparison
VIR vs ACIC Comparison
Compare VIR & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- ACIC
- Stock Information
- Founded
- VIR 2016
- ACIC 1999
- Country
- VIR United States
- ACIC United States
- Employees
- VIR N/A
- ACIC N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- ACIC Property-Casualty Insurers
- Sector
- VIR Health Care
- ACIC Finance
- Exchange
- VIR Nasdaq
- ACIC Nasdaq
- Market Cap
- VIR 724.1M
- ACIC 611.7M
- IPO Year
- VIR 2019
- ACIC N/A
- Fundamental
- Price
- VIR $5.57
- ACIC $11.00
- Analyst Decision
- VIR Buy
- ACIC Buy
- Analyst Count
- VIR 6
- ACIC 1
- Target Price
- VIR $35.67
- ACIC $16.00
- AVG Volume (30 Days)
- VIR 1.4M
- ACIC 200.8K
- Earning Date
- VIR 05-01-2025
- ACIC 05-08-2025
- Dividend Yield
- VIR N/A
- ACIC 4.51%
- EPS Growth
- VIR N/A
- ACIC N/A
- EPS
- VIR N/A
- ACIC 1.54
- Revenue
- VIR $74,205,000.00
- ACIC $296,657,000.00
- Revenue This Year
- VIR N/A
- ACIC $6.68
- Revenue Next Year
- VIR $17.69
- ACIC $7.93
- P/E Ratio
- VIR N/A
- ACIC $7.21
- Revenue Growth
- VIR N/A
- ACIC 12.20
- 52 Week Low
- VIR $4.95
- ACIC $8.82
- 52 Week High
- VIR $14.45
- ACIC $15.08
- Technical
- Relative Strength Index (RSI)
- VIR 35.32
- ACIC 42.18
- Support Level
- VIR $4.95
- ACIC $10.33
- Resistance Level
- VIR $6.02
- ACIC $11.47
- Average True Range (ATR)
- VIR 0.48
- ACIC 0.54
- MACD
- VIR -0.00
- ACIC -0.04
- Stochastic Oscillator
- VIR 29.25
- ACIC 42.49
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.